{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T23:06:35Z","timestamp":1774566395829,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["P30-026877"],"award-info":[{"award-number":["P30-026877"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005492","name":"Stanford University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ajoc.2026.102532","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T15:50:18Z","timestamp":1769701818000},"page":"102532","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Bilateral hemorrhagic occlusive retinal vasculitis and panuveitis following intravitreal faricimab injection: A clinicopathologic case study"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9914-2935","authenticated-orcid":false,"given":"Negin","family":"Yavari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8443-5519","authenticated-orcid":false,"given":"Ankur Sudhir","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9971-6652","authenticated-orcid":false,"given":"Andreas","family":"Mitsios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Horung","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dalia","family":"El-Feky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1616-837X","authenticated-orcid":false,"given":"Celine Dan-Tam","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0386-3613","authenticated-orcid":false,"given":"Cigdem","family":"Yasar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frances Andrea","family":"Anover","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5142-6840","authenticated-orcid":false,"given":"Aim-On","family":"Saengsirinavin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azadeh","family":"Mobasserian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Akhavanrezayat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2907-0050","authenticated-orcid":false,"given":"Osama","family":"Elaraby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6123-675X","authenticated-orcid":false,"given":"Ngoc Trong Tuong","family":"Than","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Bettina","family":"Toth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2755-1684","authenticated-orcid":false,"given":"Daniel","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0836-2513","authenticated-orcid":false,"given":"Christopher","family":"Or","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6024-8441","authenticated-orcid":false,"given":"Quan Dong","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ajoc.2026.102532_bib1","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.3390\/cells9081869","article-title":"Targeting angiopoietin in retinal vascular diseases: a literature review and summary of clinical trials involving faricimab","volume":"9","author":"Khan","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.ajoc.2026.102532_bib2","series-title":"FDA Approves Genentech's Vabysmo for the Treatment of Retinal Vein Occlusion (RVO)","year":"2024"},{"issue":"10326","key":"10.1016\/j.ajoc.2026.102532_bib3","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0140-6736(22)00010-1","article-title":"Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials","volume":"399","author":"Heier","year":"2022","journal-title":"Lancet"},{"issue":"10326","key":"10.1016\/j.ajoc.2026.102532_bib4","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(22)00018-6","article-title":"Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials","volume":"399","author":"Wykoff","year":"2022","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.ajoc.2026.102532_bib5","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.ophtha.2019.03.023","article-title":"Simultaneous inhibition of angiopoietin-2 and vascular endothelial growth factor-A with faricimab in diabetic macular edema: BOULEVARD phase 2 randomized trial","volume":"126","author":"Sahni","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajoc.2026.102532_bib6","doi-asserted-by":"crossref","DOI":"10.1001\/jamaophthalmol.2024.0928","article-title":"Association of occlusive retinal vasculitis with intravitreal faricimab","author":"Li","year":"2024","journal-title":"JAMA ophthalmology"},{"issue":"4","key":"10.1016\/j.ajoc.2026.102532_bib7","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/2474126420930863","article-title":"Occlusive retinal vasculitis following intravitreal brolucizumab","volume":"4","author":"Witkin","year":"2020","journal-title":"Journal of vitreoretinal diseases"},{"key":"10.1016\/j.ajoc.2026.102532_bib8","article-title":"Brolucizumab-related retinal vasculitis with exacerbation following ranibizumab retreatment: a clinicopathologic case study","volume":"20","author":"Iyer","year":"2020","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"10","key":"10.1016\/j.ajoc.2026.102532_bib9","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1001\/jamaophthalmol.2020.2810","article-title":"Retinal vasculitis after administration of Brolucizumab resulting in severe loss of visual acuity","volume":"138","author":"Kondapalli","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ajoc.2026.102532_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajoc.2020.100680","article-title":"Retinal arterial occlusive vasculitis following intravitreal brolucizumab administration","volume":"18","author":"Haug","year":"2020","journal-title":"American journal of ophthalmology case reports"},{"issue":"17","key":"10.1016\/j.ajoc.2026.102532_bib11","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1038\/s41433-023-02553-5","article-title":"The real-world efficacy and safety of faricimab in neovascular age-related macular degeneration: the TRUCKEE study\u20136 month results","volume":"37","author":"Khanani","year":"2023","journal-title":"Eye"},{"key":"10.1016\/j.ajoc.2026.102532_bib12","doi-asserted-by":"crossref","DOI":"10.1001\/jamaophthalmol.2024.3828","article-title":"Sterile intraocular inflammation associated with faricimab","author":"Cozzi","year":"2024","journal-title":"JAMA ophthalmology"},{"key":"10.1016\/j.ajoc.2026.102532_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajoc.2020.100989","article-title":"Brolucizumab-related retinal vasculitis with exacerbation following ranibizumab retreatment: a clinicopathologic case study","volume":"20","author":"Iyer","year":"2020","journal-title":"American journal of ophthalmology case reports"},{"issue":"1","key":"10.1016\/j.ajoc.2026.102532_bib14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/24741264231220224","article-title":"Retinal vasculitis after intravitreal pegcetacoplan: report from the ASRS research and safety in therapeutics (ReST) committee","volume":"8","author":"Witkin","year":"2024","journal-title":"Journal of VitreoRetinal Diseases"},{"issue":"5","key":"10.1016\/j.ajoc.2026.102532_bib15","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3390\/jcm10050981","article-title":"Inflammatory complications of intravitreal anti-VEGF injections","volume":"10","author":"Cox","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.ajoc.2026.102532_bib16","doi-asserted-by":"crossref","DOI":"10.1001\/jamaophthalmol.2024.0530","article-title":"Severe intraocular inflammation following intravitreal faricimab","author":"Thangamathesvaran","year":"2024","journal-title":"JAMA ophthalmology"},{"key":"10.1016\/j.ajoc.2026.102532_bib17","first-page":"1","article-title":"Uveitis following intravitreal injections of faricimab: a case report","author":"Palmieri","year":"2023","journal-title":"Ocul Immunol Inflamm"},{"issue":"3","key":"10.1016\/j.ajoc.2026.102532_bib18","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/ICU.0000000000000154","article-title":"Ocular inflammation associated with antivascular endothelial growth factor treatment","volume":"26","author":"Fine","year":"2015","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.ajoc.2026.102532_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100862","article-title":"Critical analysis of techniques and materials used in devices, syringes, and needles used for intravitreal injections","volume":"80","author":"Melo","year":"2021","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.ajoc.2026.102532_bib22","first-page":"1","article-title":"Proteomic profile of faricimab-associated occlusive retinal vasculitis","volume":"23","author":"Hung","year":"2025","journal-title":"Eye"},{"key":"10.1016\/j.ajoc.2026.102532_bib20","series-title":"Type IV Ypersensitivity Reaction. Statpearls. Statpearls Publishing, Copyright \u00a9 2024","author":"Marwa","year":"2024"},{"key":"10.1016\/j.ajoc.2026.102532_bib21","series-title":"Hypersensitivity. Essentials of Veterinary Immunology and Immunopathology","first-page":"49","author":"Chauhan","year":"2024"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993626000204?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993626000204?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T04:57:40Z","timestamp":1773032260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451993626000204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":22,"alternative-id":["S2451993626000204"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2026.102532","relation":{},"ISSN":["2451-9936"],"issn-type":[{"value":"2451-9936","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bilateral hemorrhagic occlusive retinal vasculitis and panuveitis following intravitreal faricimab injection: A clinicopathologic case study","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2026.102532","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102532"}}